Skip to main content
OpenTrials
Completed

NCT Number: NCT00728637

Evaluating the Effectiveness of a Family Heart Health Educational Program (The FIT-Heart Study)

The primary objective of the FIT Heart Study was to test the effectiveness of a hospital-based standardized screening and educational intervention targeted to family members of patients hospitalized with CVD, to increase adherence to CVD prevention guidelines.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–79 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Columbia University Medical Center

New York, 10032, United States

About this study

FIT Heart was a randomized controlled trial that tested a novel systems approach to increase adherence to national prevention guidelines among family members of patients hospitalized with CVD. Participants were blood relatives or cohabitants of patients hospitalized with atherosclerotic cardiovascular disease, aged 20-79 years, did not have established cardiovascular disease or diabetes, and spoke English or Spanish. Participants randomized to a special intervention group received behavioral counseling and education on diet and physical activity; personalized risk factor screening and immediate feedback; and reinforcement and follow-up throughout the year. The control group received a brief CVD prevention message in the form of a handout. All participants received standardized assessments of diet, lifestyle, and CVD risk factors at baseline and 1 year (94% follow-up). The main findings have been published showing the mean percent change in LDL-cholesterol level from baseline to 1-year improved in both groups and was not significantly different in the special intervention vs. control group (-1% vs. -2%; p=.64).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Life expectancy of at least 5 years after study entry
  • Willing to return at Year 1 for a repeat study evaluation
  • Family member was hospitalized with acute atherosclerotic cardiovascular disease, including catheter-based procedures and coronary artery bypass grafting
  • Speaks either English or Spanish

Exclusion criteria

  • Established cardiovascular disease, diabetes, active liver disease, or long-term kidney disease
  • Life expectancy less than 5 years from study entry
  • Prescription of a special diet that is not compatible with the TLC diet
  • Participation in a clinical drug study in the 3 months before study entry
  • Pregnant or planning to become pregnant

Treatment and study plan

Family Passport to Heart Health Program

Behavioral

Participants in this group received personalized heart disease risk factor screening at the baseline study visit. They were taught lifestyle approaches to risk reduction based upon national heart disease prevention guidelines, including the Adult Treatment Panel (ATP) III recommendations for improving blood cholesterol levels with a TLC diet. Participants had regular contact with study staff and will receive individualized feedback throughout the study.

General Educational Materials

Behavioral

Participants in the control group received an educational brochure about heart health at the baseline study visit.

Primary outcomes

  1. Mean percent reduction in low-density lipoprotein (LDL) cholesterol levels in the special intervention group versus the control group

    Time frame: Measured at Year 1

Secondary outcomes

  1. Mean percent change in high density lipoprotein (HDL) cholesterol levels in the special intervention group versus the control group

    Time frame: Measured at Year 1

  2. Attainment of the Therapeutic Lifestyle Change (TLC) diet

    Time frame: Measured at Year 1

  3. Change in lipoproteins, high sensitivity C-reactive protein (hsCRP), blood pressure, body mass index, waist circumference, Framingham risk, and diet score in the special intervention group versus the control group

    Time frame: Measured at Year 1

  4. Cost effectiveness of the personalized educational program to reduce LDL cholesterol levels and cost per life saved

    Time frame: Measured at Year 1

  5. Impact of hsCRP beyond traditional risk factors on attainment of prevention goals

    Time frame: Measured at Year 1

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Official study title

Effectiveness of a Family Heart Health Intervention Trial (FIT Heart I)

Acronym: FIT-Heart

Important dates

Study start
2005
Primary completion
2008
Study completion
2008
First posted
Aug 6, 2008
Registry last updated
May 15, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.